We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CMS Backs Off Negotiated Price Rules for Part D, Medicare Advantage Drugs
CMS Backs Off Negotiated Price Rules for Part D, Medicare Advantage Drugs
The Centers for Medicare and Medicaid Services has backed off a proposed rule that would have used the lowest possible payment to a pharmacy as the baseline price for Medicare.